In addition to NLRP3, higher transcript levels of AIM-2 and NLRP1 have been reported in localized skin lesions of patients with cutaneous leishmaniasis due to L. braziliensis and L. amazonensis [21]. The gene discussed is NLRP1; the disease is cutaneous leishmaniasis.